ArticleEuropean journal of medical research2025
Disturbances in amino acid metabolism in obstructive sleep apnea-hypopnea syndrome: insights from a cross-sectional study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidimensional sleep behaviours and incident obesity in postmenopausal women: a prospective cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundObstructive sleep apnea-hypopnea syndrome (OSAHS) is an established risk factor for cardiovascular and metabolic diseases. This study aimed to explore the association between OSAHS severity and plasma amino acid profiles.
methodsIn this cross-sectional, single-center study, 75 patients undergoing overnight polysomnography were enrolled and stratified into no/mild (AHI < 15/h) and moderate/severe (AHI ≥ 15/h) OSAHS groups. Plasma amino acid levels were measured using mass spectrometry. Correlation and multivariable linear regression analyses were conducted to assess associations between sleep parameters and amino acids, adjusting for age and BMI.
resultsWhen compared with the no/mild OSAHS group, patients with moderate/severe OSAHS had significantly higher levels of tryptophan, tyrosine, and glutamate (adjusted p < 0.05). After multiple testing correction, AHI showed significant positive correlations with tryptophan, isoleucine, leucine, tyrosine, valine, and glutamate. ODI was correlated with isoleucine, leucine, tyrosine, valine, and glutamate. In multivariable analysis, AHI was independently associated with higher levels of leucine (β = 0.416, p = 0.022) and isoleucine (β = 0.261, p = 0.024), while in regression models that included ODI and adjusted for BMI, methionine, glutamate and tyrosine were significantly associated with BMI, but not with ODI.
conclusionsThese findings suggest that OSAHS is associated with altered amino acid metabolism, particularly involving tryptophan and branched-chain amino acids. Such metabolic alterations appear to be linked to OSAHS severity independent of obesity. Further studies are needed to elucidate the underlying mechanisms and assess the therapeutic potential of targeting amino acid metabolism in OSAHS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.